Mode of action and clinical evaluation of platelet aggregation inhibitors
David, J.L.
Revue Medicale de Liege 42(10): 526-533
1987
ISSN/ISBN: 0370-629X PMID: 3616303 Document Number: 294672
Document emailed within 1 workday
Related Documents
Sakata, T.; Kobayashi, K.; Katayama, Y.; Takada, T.; Matsuyama, T. 1991: Clinical evaluation of platelet antagonists on the ex vivo inhibitory effects of platelet aggregation Rinsho Byori. Japanese Journal of Clinical Pathology 39(3): 315-320Arcari, M.; Aveta, R.; Brandt, A.; Cecchetelli, L.; Corsi, G.B.; Solinas, F. 1992: Synthesis and pharmacological evaluation of 2,3-dialkylindoles, "in vitro" inhibitors of thrombin-induced platelet aggregation Farmaco 47(4): 405-425
Ferreira, R. 1992: First Course of cardiovascular clinical pharmacology. II. Adjuvant therapy to thrombolysis. Anticoagulants and platelet aggregation inhibitors Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 11(3): 261-264
Nyby, M.D.; Sasaki, M.; Ideguchi, Y.; Wynne, H.E.; Hori, M.T.; Berger, M.E.; Golub, M.S.; Brickman, A.S.; Tuck, M.L. 1996: Platelet lipoxygenase inhibitors attenuate thrombin- and thromboxane mimetic-induced intracellular calcium mobilization and platelet aggregation Journal of Pharmacology and Experimental Therapeutics 278(2): 503-509
Baugh, R.F.; Hougie, C. 1981: Characterization of a new mode of defective ristocetin-induced platelet aggregation Journal of Laboratory and Clinical Medicine 97(6): 864-880
Seoane, M.R.; De Contardi, N.W. 1971: Action of pyridinolcarbamate on platelet aggregation and adhesive platelet count in normal subjects Prensa Medica Argentina 58(2): 92-99
Panchenko, V.M.; Vladimirova, A.V.; Pastorova, V.E.; Sukhanova, S.A. 1980: Fibrinolysis and its inhibitors, and platelet aggregation in rheumatism Laboratornoe Delo 11: 671-675
Zannino, L.; Salvadori, G. 1979: Platelet aggregation inhibitors. their possible use in pediatric pathology Minerva Pediatrica 31(2): 153-169
Gastpar, H. 1982: Platelet aggregation inhibitors and cancer metastasis Annales Chirurgiae et Gynaecologiae 71(3): 142-150
Luo, H.W.; Hu, X.J.; Wang, N.; Ji, J. 1988: Platelet aggregation inhibitors from Salvia miltiorrhiza Bunge Yao Xue Xue Bao 23(11): 830-834
Silveira, I.A.; Paulo, L.G.; Miranda, A.L.; Rocha, S.O.; Freitas, A.C.; Barreiro, E.J. 1991: Substituted pyrazolylhydrazones: a new class of platelet aggregation inhibitors Brazilian Journal of Medical and Biological Research 24(9): 947-951
Siess, W.; Roth, P.; Weber, P.C. 1981: Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation Thrombosis and Haemostasis 45(3): 204-207
Cajozzo, A.; Abbadessa, V.; Musso, M.; Iannitto, E. 1983: Effect of buflomedil on the behavior of platelet aggregation and its clinical evaluation in elderly patients with chronic cerebrovascular insufficiency Minerva Medica 74(28-29): 1727-1731
García Morillas, M.; Caracuel Ruiz, M.D.; Sánchez de la Cuesta, F. 1988: Interactions and undesirable side effects of platelet aggregation inhibitors Medicina Clinica 90(13): 553-555
Yasunaga, K. 1979: Inhibition of platelet aggregation by platelet inhibitory agents and its relation to their clinical effects Rinsho Byori. Japanese Journal of Clinical Pathology Suppl 40: 181-187
Blaskó, G.; Blaskó, G.; Szántay, C. 1987: Octahydroindolo[2,3-a]quinolizines and 3,4-dihydro-beta-carbolines as new inhibitors of human platelet aggregation Arzneimittel-Forschung 37(6): 667-669
Lakin, K.M.; Makarov, V.A.; Novikova, N.V.; Muliar, A.G. 1984: Mechanism of action of different inhibitors of thrombocyte aggregation Vestnik Akademii Meditsinskikh Nauk SSSR 11: 54-63
Youdim, M.B. 1986: Pharmacology of MAO B inhibitors: mode of action of (-)deprenyl in Parkinson's disease Journal of Neural Transmission. Supplementum 22: 91-105
Dal Piaz, V.; Ciciani, G.; Giovannoni, M.P. 1997: Synthesis of 4,5-functionalized-2-methyl-6-(substituted aryl)-3 (2H)-pyridazinones: a new group of potent platelet aggregation inhibitors Farmaco 52(3): 173-178
Becq-Kayal, M-Christine. 2004: Management of a patient treated with anticoagulation agents or platelet aggregation inhibitors undergoing transurethral resection of the prostate (TRUP) Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 14(1 Suppl): 14-18